CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. financial data

Symbol
CELZ on Nasdaq
Location
Phoenix, AZ
Fiscal year end
31 December
Latest financial report
10-Q - Q3 2025 - 07 Nov 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 2257% % -0.73%
Quick Ratio 0.45% % -67%
Debt-to-equity 4.3% % -1.4%
Return On Assets -85% % -41%
Operating Margin -101379% % -98%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 2,580,532 shares 48%
Common Stock, Shares, Outstanding 2,580,532 shares 94%
Entity Public Float $5,151,785 USD -22%
Common Stock, Value, Issued $2,586 USD 81%
Weighted Average Number of Shares Outstanding, Diluted 2,580,532 shares 85%

Income Statement

Label TTM Value / Value Unit Change %
Revenues $6,000 USD -45%
Cost of Revenue $2,400 USD -45%
Research and Development Expense $2,181,559 USD -4.2%
Operating Income (Loss) $6,082,766 USD -8%
Nonoperating Income (Expense) $121,358 USD -61%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $5,961,408 USD -12%
Income Tax Expense (Benefit) $0 USD
Net Income (Loss) Attributable to Parent $5,961,408 USD -12%
Earnings Per Share, Diluted -2 USD/shares 36%

Balance Sheet

Label TTM Value / Value Unit Change %
Inventory, Net $994 USD -71%
Assets, Current $5,411,541 USD -15%
Assets $5,853,003 USD -15%
Accounts Payable, Current $247,159 USD -9.7%
Accrued Liabilities, Current $0 USD -100%
Liabilities, Current $261,353 USD -21%
Liabilities $261,353 USD -21%
Retained Earnings (Accumulated Deficit) $68,699,247 USD -9.5%
Stockholders' Equity Attributable to Parent $5,591,650 USD -15%
Liabilities and Equity $5,853,003 USD -15%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $1,591,535 USD -77%
Net Cash Provided by (Used in) Financing Activities $3,354,000 USD
Net Cash Provided by (Used in) Investing Activities $0 USD -100%
Common Stock, Shares Authorized 25,000,000 shares 400%
Common Stock, Shares, Issued 2,585,532 shares 81%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $5,375,511 USD -14%
Interest Paid, Excluding Capitalized Interest, Operating Activities $0 USD
Deferred Tax Assets, Valuation Allowance $7,661,412 USD 22%
Deferred Tax Assets, Operating Loss Carryforwards $7,661,412 USD 22%
Preferred Stock, Shares Authorized 10,000,000 shares 0%
Additional Paid in Capital $74,298,311 USD 6.5%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets $115,017 USD 1.5%
Deferred Tax Assets, Net of Valuation Allowance $0 USD
Interest Expense $0 USD
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%